IPO Boutique

NewLink Genetics IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on NewLink Genetics, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
NewLink GeneticsNLNK -
NASDAQ
Last trade $11.40 $7.00 $7.003.5 million1/30/2013
Jefferies, Stifel Nicolaus Weisel
Co-Manager(s):
Health Care
Filing(s):




NewLink Genetics Quote & Chart - Click for current quote - NLNK

About NewLink Genetics (adapted from NewLink Genetics prospectus):
They are a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians.

This description is adapted from NewLink prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as NewLink "NLNK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved